PATENT CLAIM ANALYSIS

Application Number: 15944894
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "400000"]

Abstract:
The present invention is directed to a composition that can be used to deliver an antipsychotic drug such as risperidone as an injectable in-situ forming biodegradable implant for extended release providing therapeutic plasma levels from the first day. The composition is in the form of drug suspension on a biodegradable and biocompatible copolymer or copolymers solution using water miscible solvents that is administered in liquid form. Once the composition contacts the body fluids, the polymer matrix hardens retaining the drug, forming a solid or semisolid implant that releases the drug in a continuous manner. Therapeutic plasma levels of the drug can be achieved since the first day up to at least 14 days or more even up to at least four weeks.

Claim (Index 7):
The method of  claim 1 , wherein the injectable composition is administered intramuscularly.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 91.0
- Lexical Diversity: 1.62025
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13690647', '13690707', '14555287', '14555273', '14610362']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7798719792075076
- 35 USC 102 Novelty (BERT): 0.6347590917733933
- Combined Prediction Score: 0.7653606904640963
- Mean Citation Score: 487.32386800000006
- Max Citation Score: 725.46405
- Similarity Product: 512.2553884600193

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test